Mighty Mental Health has partnered with QbCheck, an objective ADHD test providing clinicians with actionable data for unbiased decision making and support.  The test, created by the global leader in ADHD testing QbCheck, is the first FDA-cleared solution to aid clinicians when diagnosing and treating ADHD in children, adolescents and adults ages 8-60 years old.

Mighty Mental Health offers both in-clinic and telehealth testing capabilities, which are conducted with a healthcare provider. Using a computer, the in-clinic assessment uses a tracking camera and time based software to measure core ADHD symptoms – activity, inattention, and impulsivity – through a 15-20-minute computer based test. Results are instantly analyzed and presented in a report that compares a patient’s results with a group of people of the same age and sex at birth without ADHD.

The data from QbCheck can be utilized to enable clinicians to determine treatment effects more accurately and efficiently. This gives patients access to tailored treatment faster – an outcome that can increase the quality of life for patients.

Three reasons testing is important:

1. Avoiding bias due to age and sex differences.
   • ADHD presents very differently, depending one’s age/sex.
   • QbCheck’s test results include data from age/sex-matched normative control groups to ensure better comparisons of your symptom severity.
2. Symptoms of ADHD can overlap with other disorders.
   • QbCheck’s objective testing provides data to better understand if symptoms fit the presentation we expect with ADHD or not.
3. Ensuring optimal outcomes
   • Finding the right treatment takes some trial-and-error, and determining treatment efficacy can be difficult.
   • QbCheck’s testing allows us to measure response to treatment to ensure you are receiving optimal results in a streamlined way.

What a patient can expect:

• Testing involves a 15 to 20 minute, nonverbal, computer-based task.
• The task measures your attention level and impulse control.
• While taking the task, movements are measured to determine if hyperactivity is present.
• Results are compared to an age and sex matched group.
• With the information from your clinical interview and rating scale(s), your clinician will interpret results to determine if you qualify for an ADHD diagnosis.

QbCheck can also be administered anytime during ADHD treatment to evaluate if the patient has improved.

Both clinicians and patients are statistically more confident when they have QbCheck results available than when these results were withheld or unavailable during the evaluation process.  The benefits of Qbtech products in practice are substantial, both for healthcare providers and patients:

• Improved access to care

• Elevated clinician confidence in diagnosis

• 50% better identification of treatment effects than
self-report rating scales (ASRS)

• Standardization of care across multiple disciplines.

For patients, we know that seeking an evaluation can be quite intimidating and you may have a lot of questions, you aren’t sure where to turn. We have added in this type of objective testing because we have heard from patients that:

• it is easy to do, yes it is boring, but because it doesn’t involve things like language, reading or math, it is not intellectually difficult

• patients get a better understanding of what their levels of activity, impulse control and attention looks like during the testing period and also being able to visually compare themselves to someone of their same age and gender at birth

• being able to measure how your treatment is working in a short, yet objective manner can lead to improved discussions with your clinician.

Very few health insurance plans cover ADHD testing for children and adults.  Mighty Mental Health will work with patients to have their health plan cover the costs of testing if available and also provide a very low self payment option.  Clinicians at Mighty Mental Health see the benefits of the software used by QbCheck constantly when testing and treating patients with ADHD.  Give us a call to discuss the benefits of the testing and the treatment plans that might follow a positive test.